Formulation of Nifedipine–Polyvinyl Pyrrolidone (PVP) Solid Dispersion System and Intrinsic Dissolution Rate Evaluation

Riza Maulana(1*), Henry Harto(2), Tiara Dewi Salindri Pratama(3)

(1) Department of Pharmaceutics, Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Surakarta, Indonesia
(2) Department of Research and Development, PT Mahakam Beta Farma, Jakarta, Indonesia
(3) Department of Pharmacy, Faculty of Mathematics and Sciences, Universitas Sebelas Maret, Surakarta, Indonesia
(*) Corresponding Author


Nifedipine is a drug that acts as an antihypertensive and anti-angina. Nifedipine is known as a drug with poor water solubility. This characteristic will affect the intrinsic dissolution rate so that it can affect the absorption process and reduce the amount of drug that reaches systemic circulation. One of the strategies to increase the intrinsic dissolution rate is developing nifedipine to solid dispersions form. This study aims to observe the intrinsic dissolution rate of nifedipine after it has been made into a solid dispersion. Four samples were prepared, including three solid dispersions of nifedipine-PVP K-30 and one sample of pure nifedipine. The results of the intrinsic dissolution tests are then interpreted through the intrinsic dissolution rate constant (G). The solid dispersions with concentration of nifedipine-PVP K-30 90%:10%; 75%:25%; 60%:40% (w/w), and pure nifedipine produced G values of 3.63; 9.33; 12.63; and 2.08 µg/mm2. min1, consecutively. It shows that the formulation of nifedipine-PVP K-30 solid dispersions has higher G values than pure nifedipine. In addition, increasing PVP K-30 concentration up to 40 % (w/w) can increase the intrinsic dissolution rate of the nifedipine-PVP K-30 solid dispersion system.


Nifedipine, solid dispersion, coprecipitation, intrinsic dissolution

Full Text:



Alves, L.D.S., de La Roca Soares, M.F., de Albuquerque, C.T., da Silva, É.R., Vieira, A.C.C., Fontes, D.A.F., Figueirêdo, C.B.M., Soares Sobrinho, J.L., and Rolim Neto, P.J., 2014. Solid dispersion of efavirenz in PVP K-30 by conventional solvent and kneading methods. Carbohydrate Polymers 104, 166–174.

Charalabidis, A., Sfouni, M., Bergström, C., and Macheras, P., 2019. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines. International Journal of Pharmaceutics 566, 264–281.

Febriyenti, F., Rahmi, S., and Halim, A., 2019. Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method. J Pharm Bioallied Sci 11, 262–267.

Fitriani, L., Haqi, A., and Zaini, E., 2016. Preparation and characterization of solid dispersion freeze-dried efavirenz – polyvinylpyrrolidone K-30. J Adv Pharm Technol Res 7, 105–109.

Frizon, F., Eloy, J. de O., Donaduzzi, C.M., Mitsui, M.L., and Marchetti, J.M., 2013. Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Powder Technology 235, 532–539.

Fudholi, A., 2013. Disolusi Dan Pelepasan Obat In-Vitro. Pustaka Pelajar, Yogyakarta.

Hadžiabdić, J., 2013. The Solubility - Intrinsic Dissolution Rate of Diazepam and Inclusion Complexes Diazepam with 2-Hydroxypropyl-β-Cyclodextrin. International Journal of Science, Technology and Society 1, 24.

Huang, Y., and Dai, W.-G., 2014. Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharmaceutica Sinica B, SI: Drug Delivery System and Pharmaceutical Technology 4, 18–25.

Jagtap, P.S., Tagad, R.R., and Shendge, R.S., 2019. A brief review on Kollidon. Journal of Drug Delivery and Therapeutics 9, 493–500.

Khoder, M., Abdelkader, H., ElShaer, A., Karam, A., Najlah, M., and Alany, R.G., 2018. The use of albumin solid dispersion to enhance the solubility of unionizable drugs. Pharmaceutical Development and Technology 23, 732–738.

Kothari, K., Ragoonanan, V., and Suryanarayanan, R., 2015. The Role of Drug–Polymer Hydrogen Bonding Interactions on the Molecular Mobility and Physical Stability of Nifedipine Solid Dispersions. Mol. Pharmaceutics 12, 162–170.

Nader, A.M., Quinney, S.K., Fadda, H.M., and Foster, D.R., 2016. Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine. AAPS J 18, 981–988.

Nair, A.R., Lakshman, Y.D., Anand, V.S.K., Sree, K.S.N., Bhat, K., and Dengale, S.J., 2020. Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology. AAPS PharmSciTech 21, 309.

Noval, N., and Malahayati, S., 2021. Teknologi Penghantaran Obat Terkendali.

Salman, Ardiansyah, Nasrul, E., Rivai, H., Ben, E., and Zaini, E., 2015. Physicochemical characterization of amorphous solid dispersion of ketoprofen–polyvinylpyrrolidone K-30. International Journal of Pharmacy and Pharmaceutical Sciences 7, 209–212.

Saraf, I., Roskar, R., Modhave, D., Brunsteiner, M., Karn, A., Neshchadin, D., Gescheidt, G., and Paudel, A., 2022. Forced Solid-State Oxidation Studies of Nifedipine-PVP Amorphous Solid Dispersion. Mol. Pharmaceutics 19, 568–583.

Sareen, S., Mathew, G., and Joseph, L., 2012. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig 2, 12–17.

Shah, N., Iyer, R.M., Mair, H.-J., Choi, D., Tian, H., Diodone, R., Fahnrich, K., Pabst-Ravot, A., Tang, K., Scheubel, E., Grippo, J.F., Moreira, S.A., Go, Z., Mouskountakis, J., Louie, T., Ibrahim, P.N., Sandhu, H., Rubia, L., Chokshi, H., Singhal, D., and Malick, W., 2013. Improved Human Bioavailability of Vemurafenib, a Practically Insoluble Drug, Using an Amorphous Polymer-Stabilized Solid Dispersion Prepared by a Solvent-Controlled Coprecipitation Process. Journal of Pharmaceutical Sciences 102, 967–981.

Shaik, J., Shaik, S., Alaparthi, N., Bachupally, A., and Punuru, M., 2013. Formulation And Evaluation Of Mefenamic Acid Solid Dispersions Using PEG-4000. International Research Journal of Pharmacy 4, 155–159.

Teleki, A., Nylander, O., and Bergström, C.A.S., 2020. Intrinsic Dissolution Rate Profiling of Poorly Water-Soluble Compounds in Biorelevant Dissolution Media. Pharmaceutics 12, 493.

Van den Mooter, G., 2012. The use of amorphous solid dispersions: A formulation strategy to overcome poor solubility and dissolution rate. Drug Discovery Today: Technologies, Formulation technologies to overcome poor drug-like properties 9, e79–e85.

Yuwono, T., 1987. Pengaruh kofeina terhadap kelarutan dan ketersediaan hayati O-Etoksibenzamida padat tikus jantan (Doctoral dissertation, Institut Teknologi Bandung, Bandung).

Zidan, H.M., Abdelrazek, E.M., Abdelghany, A.M., and Tarabiah, A.E., 2019. Characterization and some physical studies of PVA/PVP filled with MWCNTs. Journal of Materials Research and Technology 8, 904–913.

Article Metrics

Abstract view(s): 276 time(s)
PDF: 309 time(s)


  • There are currently no refbacks.